Your browser doesn't support javascript.
Percutaneous Interventional Strategies for Migraine Prevention: A Systematic Review and Practice Guideline.
Barad, Meredith; Ailani, Jessica; Hakim, Sameh M; Kissoon, Narayan R; Schuster, Nathaniel M.
  • Barad M; Department of Anesthesia (Pain Management) and Neurology and Neurological Sciences, Stanford Hospital and Clinics, Stanford, California, USA.
  • Ailani J; Department of Neurology, Medstar Georgetown University, Washington, DC, USA.
  • Hakim SM; Department of Anesthesiology, Intensive Care, and Pain Management, Ain Shams University Faculty of Medicine, Cairo, Egypt.
  • Kissoon NR; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Schuster NM; Department of Anesthesiology, University of California, San Diego, California, USA.
Pain Med ; 23(1): 164-188, 2022 Jan 03.
Article in English | MEDLINE | ID: covidwho-1455341
ABSTRACT

OBJECTIVE:

To systematically evaluate the efficacy and effectiveness of percutaneous interventional treatments for prevention of migraine through a qualitative and (when possible) quantitative analysis.

METHODS:

An expert panel was asked to develop recommendations for the multidisciplinary preventive treatment of migraine, including interventional strategies. The committee conducted a systematic review and (when evidence was sufficient) a meta-analytic review by using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) criteria and the modified Cochrane Risk of Bias analysis available in the Covidence data management program. Clinical questions addressed adults with migraine who should be offered prevention. Examined outcomes included headache days, acute medication use, and functional impairment. Acute management of migraine was outside the scope of this guideline.

RESULTS:

The committee screened 1,195 studies and assessed 352 by full text, yielding 16 randomized controlled trials that met the inclusion criteria. RECOMMENDATIONS AND

CONCLUSIONS:

As informed by evidence related to the preselected outcomes, adverse event profile, cost, and values and preferences of patients, onabotulinumtoxinA received a strong recommendation for its use for chronic migraine prevention and a weak recommendation against its use for episodic migraine prevention. Greater occipital nerve blocks received a weak recommendation for their use for chronic migraine prevention. For greater occipital nerve block, steroid received a weak recommendation against its use vs the use of local anesthetic alone. Occipital nerve with supraorbital nerve blocks, sphenopalatine ganglion blocks, cervical spine percutaneous interventions, and implantable stimulation all received weak recommendations for their use for chronic migraine prevention. The committee found insufficient evidence to assess trigger point injections in migraine prevention and highly discouraged the use of intrathecal medication.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Migraine Disorders Type of study: Experimental Studies / Prognostic study / Qualitative research / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Topics: Variants Limits: Adult / Humans Language: English Journal: Pain Med Journal subject: Neurology / Psychophysiology Year: 2022 Document Type: Article Affiliation country: Pm

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Migraine Disorders Type of study: Experimental Studies / Prognostic study / Qualitative research / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Topics: Variants Limits: Adult / Humans Language: English Journal: Pain Med Journal subject: Neurology / Psychophysiology Year: 2022 Document Type: Article Affiliation country: Pm